Marked anti-tumor effects of nivolumab on recurrent/metastatic head and neck cancer: 4 case reports

Authors :: Hiroki Kagoshima
Hirotaka Yamamoto
Atsushi Taguchi
Koki Hasebe
Shintaro Fujimura
Yusuke Okanoue
Tsuyoshi Kojima
Kazuhiko Shoji
Ryusuke Hori
Source :: Tenri Medical Bulletin. 22:79-85
Publication Year :: 2019
Publisher :: Tenri Foundation, Tenri Institute of Medical Research, 2019.

Subjects :: Antitumor activity
Oncology
medicine.medical_specialty
business.industry
Internal medicine
Head and neck cancer
Medicine
Nivolumab
business
medicine.disease

Full Text Access

Tools